These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6632918

  • 21. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients.
    Velasco M, Silva H, Morillo J, Pellicer R, Urbina-Quintana A, Hernández-Pieretti O.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S225-7. PubMed ID: 6177961
    [Abstract] [Full Text] [Related]

  • 22. Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Wada S, Nakayama M, Masaki K.
    Clin Ther; 1982; 5(2):163-73. PubMed ID: 6130841
    [Abstract] [Full Text] [Related]

  • 23. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 24. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD, Huff M, Barnett PA.
    Can J Clin Pharmacol; 2000 Dec; 7(1):32-7. PubMed ID: 10822211
    [Abstract] [Full Text] [Related]

  • 25. Amiloride with or without salbutamol versus placebo: effects on lipoproteins in hypertensive patients treated with timolol-hydrochlorothiazide.
    Spence JD, Wong DG.
    J Hypertens Suppl; 1986 Dec; 4(5):S515-8. PubMed ID: 3553482
    [Abstract] [Full Text] [Related]

  • 26. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Dec; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 27. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD.
    Clin Ther; 1994 Dec; 16(3):490-504. PubMed ID: 7923316
    [Abstract] [Full Text] [Related]

  • 28. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y, Gagné C.
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
    Pac-Kozuchowska E.
    Ann Agric Environ Med; 2007 Apr; 14(1):25-9. PubMed ID: 17655173
    [Abstract] [Full Text] [Related]

  • 30. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP.
    Drugs; 1986 Oct; 32(4):335-57. PubMed ID: 2877846
    [Abstract] [Full Text] [Related]

  • 31. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 32. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH, Wachtell K, Beevers G, Dahlöf B, de Simone G, Devereux RB, de Faire U, Fyhrquist F, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Lyle PA, Nieminen MS, Omvik P, Oparil S, Wedel H.
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [Abstract] [Full Text] [Related]

  • 33. [Modification of lipoprotein metabolism by antihypertensive therapy].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1989 Apr 01; 44(7):197-200. PubMed ID: 2662653
    [Abstract] [Full Text] [Related]

  • 34. Antihypertensive drug therapy and coronary heart disease risk.
    Schoenberger JA.
    J Fam Pract; 1993 Jan 01; 36(1):70-3, 77-84. PubMed ID: 8419507
    [Abstract] [Full Text] [Related]

  • 35. Effect of mepindolol on serum lipids.
    Martignoni A, Perani G, Finardi G, Mastropasqua E, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 01; 20(11):543-5. PubMed ID: 7174157
    [Abstract] [Full Text] [Related]

  • 36. Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
    Bernik MM, Heimann JC, Nakandakare ER, Cazita PM, Nunes VS, Rocha JC, Neves MQ, Quintão EC.
    Can J Physiol Pharmacol; 2005 Jul 01; 83(7):617-23. PubMed ID: 16091787
    [Abstract] [Full Text] [Related]

  • 37. [Antihypertensive agents and blood lipids--The Oslo study].
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    Wien Med Wochenschr; 1982 Jul 01; 132 Spec No():10-3. PubMed ID: 7080512
    [No Abstract] [Full Text] [Related]

  • 38. Effect of propranolol and prazosin on blood lipids. The Oslo Study.
    Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG.
    Lancet; 1980 Jul 05; 2(8184):4-6. PubMed ID: 6104255
    [Abstract] [Full Text] [Related]

  • 39. [Effect of hypotensive agents on the lipid composition of the blood].
    Preobrazhenskiĭ DV, Sinitsyn VE.
    Ter Arkh; 1985 Jul 05; 57(11):138-42. PubMed ID: 2867613
    [No Abstract] [Full Text] [Related]

  • 40. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Jul 05; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.